Magnesium as a diagnostic marker of cancer by unknown
MEETING ABSTRACT Open Access
Magnesium as a diagnostic marker of cancer
Wojciech Marciniak1*, Magdalena Muszyńska1, Katarzyna Jaworska-Bieniek2, Katarzyna Kaczmarek2,
Grzegorz Sukiennicki2, Marcin Lener2, Katarzyna Durda2, Tomasz Huzarski2, Tomasz Byrski2, Jacek Gronwald2,
Oleg Oszurek2, Cezary Cybulski2, Tadeusz Dębniak2, Antoni Morawski1, Anna Jakubowska2, Jan Lubiński1,2
From Annual Conference on Hereditary Cancers 2014
Szczecin, Poland. 25-26 September 2014
Magnesium plays a key role in many essential cellular
processes. It is recognized that magnesium deficiency may
lead to many disorders like cardiovascular disease, diabetes
mellitus, hypertension, myocardial infarction or even
cancer. Connection between magnesium concentration in
body fluids and cancer occurrence still becomes unclear.
Magnesium ions are crucial cofactors for enzymes
involved DNA repairing. Thereby magnesium deficiency
may result in genomic instability and consequently cause
cancer.
The aim of our study was to investigate if serum magne-
sium concentration may be useful biomarker for early
detection of prostate and laryngeal cancer and also if
serum Mg concentration may be marker of selection for
CT of the lung, laryngeal examination, PSA levels or pros-
tate biopsy. Independently we have investigated a prospec-
tive study where our aim was to investigate if the serum
Mg concentration is a marker of increased breast cancer
risk. We performed retrospective investigation in laryngeal
cancer patients (n = 123) and prostate cancer groups
(n = 166). Each group was compared with healthy controls
group, which consists of equal to cases amount of con-
trols. Controls and cases were matched by age, gender,
negative supplementation status, negative status of hormo-
nal contraceptives and smoking status. In the prospective
study (sera collected before cancer diagnosis) Mg concen-
tration was determined in BRCA (-) women and compared
to controls. Mg serum levels (<17000 µg/l and
>20800 µg/l) are associated with 2-fold higher occurrence
of laryngeal cancers. Magnesium serum level is not a use-
ful marker for selection of the patients for prostate cancer
screening. Finally, magnesium concentration may be a
marker for breast cancer risk in BRCA (-) patients but
further investigation is needed.
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